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Abstract: Carbapenem-resistant bacteria are a major cause of diabetic foot (DF) infection. They are resistant to almost all 
available antimicrobial agents and lead to increased hospital costs. The clinical and microbiological characteristics 
of DF infection due to these microorganisms and the association of DF with outcomes such as mortality and 
amputation are not yet well established. This was a retrospective cohort study involving 60 vascular surgery patients 
who were admitted to Nossa Senhora da Conceição Hospital due to DF infection caused by carbapenem-resistant 
bacteria and who underwent debridement or amputation, and a control group with 60 randomly selected patients. 
The analyzed parameters were mortality and amputation rates and patients’ epidemiological and microbiological 
profiles. A significant association was observed between bacterial resistance and previous amputation, previous 
hospitalizations, and DF ulcer classification into ischemic and neuroischemic; however, there were no differences 
in mortality and amputation rates between the groups, even after using the Charlson comorbidity index. Although 
DF infections by carbapenem-resistant bacteria were not statistically associated with worse outcomes, their study is 
important given that there are few therapeutic options for treating these specific infections.
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Resumo: As bactérias carbapenêmico-resistentes são uma causa importante de infecção no pé diabético (PD). Elas são 
resistentes à maioria dos agentes antimicrobianos disponíveis e estão associadas com aumento dos custos 
hospitalares. O perfil clínico e microbiológico da infecção no PD por esses microorganismos e a associação do 
PD com desfechos como mortalidade e amputação não são bem estabelecidos. Foi realizado um estudo de coorte 
retrospectiva envolvendo 60 pacientes internados na cirugia vascular do Hospital Nossa Senhora da Conceição 
devido a infecção do PD por bactérias carbapenêmico-resistentes e que foram submetidos a amputação ou 
desbridamento e um grupo controle de 60 pacientes randomicamente selecionados. Foram analisados o perfil 
epidemiológico e microbiológico desses pacientes bem como as taxas de mortalidade e amputação. Observou-se 
uma associação significante entre resistência bacteriana e amputação prévia, hospitalização prévia e classificação 
do PD em isquêmico e neuro-isquêmico. No entanto, não houve diferença nas taxas de mortalidade e de amputação 
entre os grupos, mesmo com o uso do escore de comorbidades de Charlson. Apesar das infecções no PD por 
bactérias carbapenêmico-resistentes não serem associadas estatisticamente com piores desfechos, seu estudo é 
importante em função das poucas opções terapêuticas disponíveis para tratar essas infecções. 
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1 INTRODUCTION
Diabetic foot (DF) is used to describe 
the changes and complications that occur either 
alone or in combination in the feet and legs 
of diabetic patients.1 DF involves deep-tissue 
infection, ulceration, or necrosis associated with 
neurological abnormalities and various degrees of 
peripheral artery disease.2 DF is one of the most 
feared complications of diabetes and is a frequent 
cause of hospitalization, which is markedly 
associated with morbidity and mortality. The 
treatment of lesions is lengthy with a considerable 
rate of amputation.3
The profiles of these lower-limb lesions 
make them highly susceptible to acquisition, 
growth, and dissemination of antibiotic-resistant 
organisms due to their chronification potential, 
repeated use of antibiotics, and frequent visits to 
hospitals and healthcare facilities.2
Carbapenem-resistant bacteria are an 
important group among DF infection-causing 
bacteria. The fact that these microorganisms have 
different mechanisms of resistance is a significant 
challenge to health institutions because these 
pathogens are resistant to almost all available 
antimicrobial agents, which leads to high 
morbidity and mortality rates.4-9 The clinical and 
microbiological characteristics of DF infection by 
carbapenem-resistant bacteria and its association 
with outcomes such as mortality and amputation 
are not yet well established, which warrants the 
study of this topic.
2 METHODS
This was a retrospective cohort study 
involving vascular surgery patients admitted to 
the Nossa Senhora da Conceição Hospital (HNSC) 
due to DF infection caused by carbapenem-
resistant bacteria.
Patients who required surgical treatment 
(debridement or amputation) in 2013 due to 
infection by these bacteria were identified and 
monitored for at least 1 year to determine the 
rates of mortality and amputation; number of 
hospitalizations; epidemiological, clinical, and 
microbiological characteristics; and previous use 
of antibiotic therapy.
A total of 71 patients had cultures positive 
for carbapenem-resistant bacteria. Of these, 11 
were excluded because they did not have type-
2 diabetes mellitus. Finally, 60 patients were 
included. The same outcomes were evaluated in 
all 60 diabetic patients with foot infections caused 
by the same carbapenem-sensitive bacteria, with 
the control group being randomly selected.
The sample used in this study comprised 
all patients of the HSNC Vascular Surgery 
Department with DF infection caused by 
carbapenem-resistant bacteria identified in the 
cultures of tissues debrided or amputated in 2013.
After approval from the Lutheran 
University of Brazil (ULBRA) Research Ethics 
Committee (Certificate of Presentation for Ethical 
Evaluation no. 37036614.7.0000.5349), the project 
was submitted to the Brazilian National Council 
of Ethics in Research using the Plataforma 
Brasil online system and approved through the 
same system before the research was started. 
The information was obtained from discharge 
summaries and the in-hospital and outpatient 
clinical-course data present in the electronic 
medical records. The data were collected using 
a data collection form designed by the authors. 
Because of the retrospective nature of the study, 
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a waiver for informed consent was granted by 
the institutional review board, and informed 
consent was not obtained before inclusion of the 
participants in the study.
The analyzed outcomes were hospital 
mortality, post-hospitalization mortality, and 
amputation rate. Hospital mortality was defined 
as deaths occurring during the hospitalization 
period, when the diagnosis was made via 
culture-based detection of bacterial resistance 
or sensitivity. Post-hospitalization mortality was 
defined as deaths occurring after this period. In 
addition, the bacterial cultures were reviewed and 
microbiological characteristics of the infections 
were determined.
Comorbidities are strong outcome 
predictors as well as are confounders. Therefore, 
based on the collected data, the Charlson 
comorbidity index and age-adjusted Charlson 
comorbidity index were calculated for each 
patient. This is a method for the classification of 
severity that uses data of secondary diagnoses to 
predict the risk of a patient’s death. It is calculated 
as the sum of scores assigned to each condition 
and age. Higher scores indicate higher 10-year 
mortality risk.
2.1 INCLUSION AND EXCLUSION CRITERIA 
FOR THE PATIENT GROUP
The inclusion criteria were as follows: 
patients >18 years, with diabetes mellitus, and 
with a culture of debrided or amputated tissue 
performed in 2013 showing only resistance to 
carbapenems. The exclusion criteria were as 
follows: patients without diabetes mellitus, with a 
culture showing any resistant bacterium before or 
after 2013, or a swab culture with bacteria resistant 
to any group of antibiotics.
2.2 INCLUSION AND EXCLUSION CRITERIA 
FOR THE CONTROL GROUP
The inclusion criteria were as follows: 
randomly selected individuals >18 years, with 
diabetes mellitus, with a culture of debrided 
or amputated tissue performed in 2013 in 
which carbapenem-sensitive enterobacteria or 
Pseudomonas aeruginosa were identified. The 
exclusion criteria were as follows: individuals 
without diabetes mellitus or with cultures 
performed in, before, or after 2013 in which any 
resistant bacterium was detected.
2.3 STATISTICAL ANALYSIS
The results were analyzed using descriptive 
analysis and non-parametric tests to evaluate 
the association with the investigated categorical 
variables. Chi-squared test was used when the 
assumptions were met for such cases; otherwise, 
Fisher’s exact test was used for the pertinent 
variables. Student’s t-test for age was used to 
assess significant differences between the patient 
and control groups with regard to the numerical 
variables, given that age distribution was found 
to be normal. Mann–Whitney’s test was used to 
assess the association with the remaining variables 
because their distribution was not normal. The 
data were electronically processed and analyzed 
with the creation of a database (Excel® 2007) 




Our study sample comprised 120 patients; 
60 in the group of infections caused by carbapenem-
resistant bacteria and 60 in the control group. The 
mean age of patients was 64.33 and 63.30 years in 
Stela Karine Braun, Márcia Susana Nunes Silva
Disponível em: https://portalperiodicos.unoesc.edu.br/evidencia4
the patient and control groups, respectively. No 
significant difference was observed in age between 
the groups. Most individuals were men in both 
groups, with 68.3% (41 patients) in the patient 
group and 70% (42 patients) in the control group.
Some clinical and microbiological 
characteristics are described in Table 1. Bacterial 
resistance was more prevalent among patients 
with ischemic or neuroischemic DF (p = 0.008), 
those who had been previously amputated 
(p = 0.028), and those previously hospitalized 
(p = 0.024). Further, there was no statistically 
significant difference between the groups with 
regard to previous antibiotic therapy (p = 0.070).
There was a predominance of 
enterobacteria in the carbapenem resistance 
group (85.5%), whereas this percentage was 65.2% 
in the control group (p = 0.013). Coinfection with 
two resistant bacteria occurred in four cases in 
the patient group, whereas in the control group 
coinfection with two bacteria of the same profile 
but sensitive to carbapenems occurred in nine 
cases. Morganella morganii morganii was the most 
frequently detected resistant bacterial species, 
accounting for 42.2% of infections. In contrast, in 
the control group, the most common species was 
Pseudomonas aeruginosa, accounting for 34.8% of 
infections.
The outcomes analyzed in our study were 
mortality and amputation rates, and no significant 
difference was observed between the groups in 
either of them (Table 2). However, there was a 
statistically non-significant difference in hospital 
mortality and amputation rate, with higher values 
obtained in the group of patients with infection 
caused by carbapenem-resistant bacteria, which 
may be of clinical importance.
Table 1 – Clinical and microbiological characteristics of the carbapenem-resistant bacterial infection and control groups
Variables Groups P-value
Cases N (%) Control N (%)
Diabetic foot 0.008
Neuropathic 19 (31.7) 34 (56.7)
Ischemic 30 (50) 23 (38.3)
Neuroischemic 11 (18.3) 3 (5)
Previous hospitalizations 0.024
Yes 43 (71.7) 31 (51.7)
No 17 (28.3) 29 (48.3)
Previous amputation 0.028
Yes 35 (58.3) 23 (38.3)
No 25 (41.7) 37 (61.7)
Previous use of antibiotics 0.07
Yes 21 (35.0) 30 (50)
No 39 (65.0) 30 (50)
Group of bacteria (co-infections included) 0.013**
Enterobacteria 53 (85.5)* 45 (65.2)
Pseudomonas 9 (14.5)* 24 (34.8)
Note: *Two cases of carbapenem-resistant Acinetobacter are included. ** Fisher’s exact test
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Yes 3 (5) 1 (1.7)
No 57 (95) 59 (98.3)
Post-hospitalization mortality 1
Yes 6 (10) 6 (10)
No 54 (90) 54 (90)
Total mortality (Hospital + Post-hospitalization) 0.591*
Yes 9 (15) 7 (11.7)
No 51 (85) 53 (88.3)
Amputation 0.841
Yes 42 (70) 43 (71.7)
No 18 (30) 17 (28.3)
Upper amputation 0.323
Yes 17 (40.5) 13 (30.2)
No 25 (59.5) 30 (69.8)
Note: *Fisher’s exact test. 
other prognostic scores such as APACHE and 
SOFA because of the retrospective nature of the 
study and the unavailability of some data in the 
electronic records.
The Charlson comorbidity index and the 
age-adjusted Charlson comorbidity index were 
analyzed with regard to the variables mortality, 
amputation, and major amputation; and no 
differences were noted in mortality or amputation 
rates between the groups.
Table 3 shows the nonadjusted and age-
adjusted Charlson scores with regard to the 
outcome death. In the patient group, there was a 
significant difference in the nonadjusted and age-
adjusted Charlson indices between patients who 
died and those who survived, i.e., the patients 
who died had a higher score in both indices. In the 
control group, there was a significant difference 
only in the age-adjusted Charlson score, with a 
The outcomes were analyzed for each group 
of bacteria (enterobacteria and Pseudomonas) and 
no difference was observed between the groups. 
Considering the enterobacteria group, there was 
no difference in hospital mortality (p = 0.379) and 
total mortality (p = 0.362) between the groups. 
Moreover, there was no difference in the rates of 
amputation (p = 0.522) and major amputation 
(p = 0.400). Considering the Pseudomonas group, 
there were no deaths during hospitalization in any 
of the groups. In addition, there was no difference 
in total mortality (p = 0.095), amputation 
(p = 0.400), and upper amputation (p = 0.510) 
rates between the groups.
Because there was no significant difference 
in gross mortality rates between the groups, the 
Charlson comorbidity index was used to assess the 
association between the patients’ comorbidities 
and risk of death. It was not possible to calculate 
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higher mean obtained among patients who died. 
This difference in scores between patients who 
lived and those who died suggests that mortality is 
Table 3 – Relationship between comorbidity scores and the outcome death




Carbapenem-resistant infection case group
Charlson comorbidity index No 51 2.8 1.2 2 6 0.002a
Yes 9 4.78 2.17 2 9
Age-adjusted Charlson comorbidity 
index
No 51 4.8 1.68 2 9 0.008a
Yes 9 6.89 2.37 5 12
Control group
Charlson comorbidity index No 53 2.77 1.37 2 9 0.080a
Yes 7 4.43 2.88 2 10
Age-adjusted Charlson comorbidity 
index
No 53 4.64 1.86 2 13 0.043a
Yes 7 6.43 2.51 4 11
Note: a Mann–Whitney’s test.
associated more with the severity of the patient’s 




There are various factors associated with 
the increase in the rate of resistance, and they are 
classified into two categories: inappropriate use 
of antimicrobial agents and failure in hospital 
hygiene that favor cross-infection. However, there 
are few data on the risk factors involved in the 
colonization and infection of DF lesions.10
Our study sample comprised mostly of 
elderly male patients with poorly controlled 
diabetes mellitus, which demonstrates the 
complications that arise from the chronic nature of 
diabetes mellitus and the importance of adequate 
glycemic control. The factors associated with 
DF infection by carbapenem-resistant bacteria 
were the classification of DF into ischemic or 
neuroischemic and a history of amputation and 
hospitalization. The etiology of the lesions in the 
total sample (120 patients with DF infections) 
was neuropathic (44%), ischemic (44%), or 
neuroischemic (12%). A study with 180 patients 
with DF was conducted and the authors10 reported 
that the DF lesions were ischemic or neuroischemic 
in 63% patients and neuropathic in 37% of the 
sample. Ischemic wounds are characterized by 
complications in micro and macrocirculation, 
which lead to low penetration of antibiotics in the 
lower limbs tissues and longer exposure to them, 
which in turn can induce bacterial resistance. 
They also showed that the type of ulcer (ischemic) 
was an independent risk factor for DF infection 
caused by multiresistant organisms.11
The relationship between previous 
amputation and bacterial resistance may be 
explained by frequent contact with healthcare 
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services, previous hospitalizations, and previous 
use of antimicrobial agents. In another study,2 
32% patients had already undergone amputation. 
Those subjected to above-knee amputations had 
an increased risk of subsequent contralateral 
amputation. In our study, almost 60% patients in 
the patient group had undergone amputation.
Previous use of antibiotics was not 
significantly associated with bacterial resistance 
in our study. An association between previous use 
of antibiotic therapy and bacterial resistance has 
been reported. There is a significant association 
between previous antibiotic therapy and infection 
by a resistant microorganism.12 Other authors11 also 
stated that the prolonged use of broad-spectrum 
antibiotics increases the risk of emergence of 
multiresistant organisms. A limitation of our 
study was the fact that this information was 
not always documented because there were no 
data on the use of antibiotics before the studied 
hospitalization period.
In our study, there was a significant 
association between previous hospitalizations 
and bacterial resistance, a finding that is in line 
with the literature. DF infections caused by 
multiresistant organisms were associated with 
a history of hospitalization, suggesting that the 
infections were acquired during hospitalization 
via cross-infection.2,10-12
We evaluated the data regarding bacterial 
cultures, and found a statistically significant 
dominance of enterobacteria in the patient group 
relative to the other groups of bacteria. The 
microbiological characteristics of DF infections 
have been described in several studies conducted 
in the last 25 years, but the results are varied 
and often contradictory. These discrepancies 
may be due to differences in the causative 
organisms, which change with time, geography, 
and infection type, and severity.13 Previous use 
of antibiotic therapy and the selected method 
of sample collection and analysis also influence 
the diversity of pathogens in DF among different 
institutions.14 A study15 reported a predominance 
of Gram-negative bacteria in DF infections, with a 
considerable percentage of Morganella morganii. 
These authors related a lack of education and 
hygiene in their study group with the presence 
of these bacteria. The conditions of patients in 
our study were similar to those of patients in that 
study, conducted in the Brazilian state of Ceará. 
Another research16 also reported a considerable 
amount of infections by Morganella. This finding 
may also be related with poor hand hygiene, use of 
broad-spectrum antimicrobial agents, and to poor 
local physical conditions. It was also reported by 
other authors17 that Gram-negative bacteria were 
more common isolates in DF infections, similarly 
to many studies conducted in India.
Several studies have investigated whether 
resistance to carbapenems is associated with 
increased mortality.6,7,9,10,18,19 This association was not 
observed in our study, which is in line with several 
reports that deny this association. In addition, there 
was a considerable rate of mortality in the patient 
and control groups because the majority of patients 
were older individuals with a high Charlson score 
and with various comorbidities who experienced an 
infectious episode during hospitalization.
The differences in mortality may be due 
to organism-, patient-, and treatment-related 
factors. As with other infections caused by 
antibiotic-resistant pathogens, patients with 
carbapenem-resistant Enterobacteriaceae tend to 
exhibit greater disease severity and more comorbid 
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conditions than those with infections caused by 
carbapenem-susceptible Enterobacteriaceae.19
Multiresistant organisms have a 
deleterious effect on the outcome of severe acute 
infections such as bacteremia or pneumonia, but 
not on chronic diseases like DF, for which active 
antimicrobial agents are available.10
The effect of antibiotic resistance on the 
outcomes of patients with nosocomial infections 
is controversial. Despite the acceptance of the idea 
that bacterial resistance is associated with increased 
morbidity and mortality, several authors did not 
observe this relationship. Comorbidities, delays in 
starting appropriate antibiotic therapy, and disease 
severity in patients infected by multiresistant 
pathogens may be important confounding factors. 
Appropriate adjustment of these confounding 
factors is essential in studies that determine the 
effect of antimicrobial resistance.18
In our study, there was no difference 
in the amputation rate between the groups. 
With regard to major amputation, the group of 
resistant infections had four more amputations 
than the control group, but the difference 
was not statistically significant. As there was 
no statistically significant difference in gross 
mortality or amputation rates between the groups, 
both the nonadjusted and age-adjusted Charlson 
comorbidity indices were used to assess the effect 
of previous diseases on the patients’ outcomes. 
However, no significant differences were observed 
in these indices between the groups. The analysis 
of the outcomes (mortality and amputation rates) 
and of the two Charlson comorbidity indices in 
the groups showed no significant differences. The 
Charlson scores were higher in patients who died 
than in those who survived, i.e., the patients who 
died had more associated conditions that were 
probably the causes of death.
The main limitation of this study is its 
observational and retrospective nature, with 
difficulties in data retrieval from medical records. 
In addition, this was a single-center study and the 
results cannot be generalized to other centers.
4 CONCLUSION
Although DF infections by carbapenem-
resistant bacteria were not statistically associated 
with worse outcomes, their study is important, 
especially regarding preventive measures that 
avoid their occurrence, given that there are few 
options for the treatment of these infections. 
To date, there is no study on DF infections by 
carbapenem-resistant bacteria. Therefore, further 
studies on this topic are required to confirm the 
findings of our study.
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